imidazole has been researched along with dactinomycin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Itoh, T; Kasahara, S | 1 |
| Carland, K; Kline, EL; Smith, TJ | 1 |
| Carland, KC; Kline, EL; Smith, TJ; Warren, JT | 1 |
| Agostinis, P; de Witte, P; Hendrickx, N; Moens, U; Piette, J; Seternes, OM; Vandenheede, JR; Volanti, C | 1 |
5 other study(ies) available for imidazole and dactinomycin
| Article | Year |
|---|---|
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Rat T lymphocyte progenitors in bone marrow can be induced to express more Thy 1.
Topics: Animals; Antigens, Surface; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cell Line; Cell Separation; Dactinomycin; Epithelial Cells; Erythromycin; Flow Cytometry; Hydroxyurea; Imidazoles; Isoproterenol; Propranolol; Rats; T-Lymphocytes; Thy-1 Antigens | 1985 |
Triiodothyronine repression of imidazole-induced tyrosinase expression in B16 melanoma cells.
Topics: Animals; Catechol Oxidase; Cell Division; Cell Line; Dactinomycin; Dose-Response Relationship, Drug; Imidazoles; Melanoma; Mice; Monophenol Monooxygenase; RNA, Messenger; Triiodothyronine; Triiodothyronine, Reverse | 1986 |
Effect of testosterone on imidazole-induced tyrosinase expression in B16 melanoma cell culture.
Topics: Animals; Cycloheximide; Dactinomycin; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Induction; Epitestosterone; Imidazoles; Melanoma, Experimental; Mice; Testosterone; Tumor Cells, Cultured | 1988 |
Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.
Topics: Anthracenes; Apoptosis; Blotting, Western; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; Mutation; NF-kappa B; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Perylene; Photochemotherapy; Precipitin Tests; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Signal Transduction; Sulfonamides; Time Factors; Transcription, Genetic; Transfection; Up-Regulation | 2003 |